Talking About Glaucoma (AAC)

Robert M Schertzer, MD, MEd, FRCSC

Talking About Glaucoma (AAC)

A Health podcast

Good podcast? Give it some love!
Talking About Glaucoma (AAC)

Robert M Schertzer, MD, MEd, FRCSC

Talking About Glaucoma (AAC)

Episodes
Talking About Glaucoma (AAC)

Robert M Schertzer, MD, MEd, FRCSC

Talking About Glaucoma (AAC)

A Health podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of Talking About Glaucoma

Mark All
Search Episodes...
Visit https://TalkingAboutGlaucoma.com to find all my social feeds, subscribe to the newsletter, provide feedback and Register as a Guest if you want to be on a future episode.More information about Dr Mahnia Madan can be found at https://www.t
In this episode, I talk with Abdullah “Abed” Sarhan, CEO and Co-founder of Retinal Logic, about the company's use of AR and VR technology for vision screening. Abbott shares his background in deep learning and healthcare, the development of the
[Please change your subscription to the mp3 feed instead of the AAC feed as I will be stopping this AAC feed in 2024…see https://TalkingAbout Glaucoma.com for all the links to subscribe.]In this episode, I go beyond the basics of Optical Cohere
Intro:In this episode, I discuss Plateau Iris with Dr Shivani Kamat, Assistant Professor of Ophthalmology and Glaucoma Fellowship Program director at UT Southwestern. She also founded and co-chairs Women in Glaucoma. Today's discussion includes
Intro:In this episode, I talk with Carla Siegfried, Jacquelyn E. and Allan E. Kolker, MD Distinguished Professor of Ophthalmology and Vice-Chair of Diversity, Equity, and Professionalism at Washington University School of Medicine, about the go
TAG #35 GEDDE Steve - Glaucoma surgical trials: lessons learnedIntro:There have been many trials proving surgical intervention does indeed reduce the risk of progressive glaucoma damage for our patients. These include Treatment vs No Treatment
Intro: Welcome to Talking About Glaucoma episode #34 for May 7, 2021. Here’s another recording from the vaults that is getting to see the light of day. It is one of 3 episodes recorded in person back in late February 2020 just before Covid de-r
Intro: Welcome to Talking About Glaucoma episode #33 for December 31, 2020. I bet you're glad this year is over! I'm still digging through the vaults to post episodes like this gem and have a few more that will go live soon. Email me at podcas
Intro:My apologies for the >1 year gap since my last episode. It's been quite the year moving my work back to full time in Vancouver and providing patient care in our new normal of a pandemic. There are many more episodes that have been recorde
The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil
Intro:Welcome back to Talking About Glaucoma, a podcast of indeterminate length and frequency. I’m your host Robert Schertzer, a Glaucoma Specialist from Vancouver, BC Canada. To help produce future shows more frequently, I will no longer inclu
In this episode, I’m talking with Ron Fellman from Glaucoma Associates of Texas about the Fellman Fluid Wave and its clinical implications in glaucoma surgery.Episode Chapters:Intro: Ron FellmanGlaucoma Associates of TexasFluid Wave: what it is
I sat down with Chris Johsnon at a recent American Glaucoma Society meeting to discuss some of my pet peeves about visual field testing and what lies on the horizon. Chris is Professor of Ophthalmology and Visual Sciences at the University of I
In this episode, Tom Harbin, from Eye Consultants of Atlanta, and I discuss ethical issues in the medical treatment of glaucoma. This includes generic vs brand name drugs, the need to shop around for the best price, and looking out for talks fr
In this episode, I talk with Tracy Wright, now based at Kaiser Permanente in Washington DC. He was at the Bascom Palmer Eye Institute at the University of Miami when we recorded this conversation. The implications immediately effected how I loo
In this episode, I talk with Nelson Winkler (a medical student at the time) and Cheryl Khanna (Glaucoma attending) at The Mayo Clinic, who analyzed the outcomes of their team based model for Glaucoma care. This physician- led model began in 200
[This AAC .m4a version has chapter markers and artwork embedded in the podcast to enhance the experience on devices/apps that support this, which includes most podcasting apps on iOS and Android devices. It is the preferred version for experien
[This AAC .m4a version has chapter markers and artwork embedded in the podcast to enhance the experience on devices/apps that support this, which includes most podcasting apps on iOS and Android devices. It is the preferred version for experien
In this episode, I talk with Florent Aptel, a glaucoma specialist in Grenoble, France, about his work in developing a modern day hi frequency ultrasound as a treatment for glaucoma in its early stages. Their group has developed a device that se
In this episode, Dr Blumenthal and I discuss the not so obvious technique of peripheral laser iridotomy, emphasizing the shift away from the 12 o'clock position to a temporal location for most patients. We discuss the rationale for this shif
In this episode, Dr Berlin and I discuss the elusive quest to have the Excimer Laser Trabeculostomy (ELT) that he pioneered gain traction after 30 years of development. (This is the AAC enhanced version with chapter markers and images optimi
In this episode, Dr Solish and I discuss the art of “needling” a filtering bleb, or as he likes to call it, a Slit Lamp Revision (SLR), to resuscitate its function. Beginning with the history of when he first thought of the idea as a residen
In this episode, Dr Krishna and I discuss the Eye HandBook app that he and partner Dr Ken Lord developed. This app, available for both iOS and Android devices, has been a huge success. How can you disagree when the price is FREE and it is lo
In this episode, Dr Sarkisian and I discuass his use of Ologen branded collagen matrix in attempts to improve the success of glaucoma surgery. This novel modification has yet to gain widespread support and would still be considered experimen
In this episode, Dr De Moraes and I discuss risk factors for visual field progression in patients already diagnosed with and being treated for glaucoma.
Rate
Contact This Podcast

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features